Limited T cell response to SARS-CoV-2 mRNA vaccine among patients with cancer receiving different cancer treatmentsAlfonso Cortés, Alfredo Carrato, Cristina Saavedra et al.|European Journal of Cancer|2022Cited by 30
Investigation of tumor biomarkers as response predictors in a monotherapy study with lapatinib (L) as a first line treatment in ErbB2 amplified women with breast cancerHenry Gómez, Adrián Martín, Miguel A. Chavez et al.|Journal of Clinical Oncology|2007Cited by 11